Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
5.01
+0.53 (11.83%)
Oct 8, 2025, 10:42 AM EDT - Market open
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $3.41 million as of October 8, 2025. Its market cap has increased by 27.02% in one year.
Market Cap
3.41M
Enterprise Value
-3.43M
1-Year Change
27.02%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $3.41M, a decrease of -94.06%. That is a compound annual growth rate of -49.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 3.05M | 10.83% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 765.84B |
| Johnson & Johnson | 453.44B |
| AbbVie | 404.35B |
| UnitedHealth Group | 327.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.43B |